Question 1

What is Santhera Pharmaceuticals?

Accepted Answer

Santhera Pharmaceuticals is a Company.

Question 2

How often does Santhera Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was Santhera Pharmaceuticals first tracked by NewsDesk?

Accepted Answer

First tracked on Apr 23, 2026.

Question 4

When was Santhera Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 02, 2026.

Question 5

What is Santhera Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 23 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Santhera Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Santhera Pharmaceuticals?

Accepted Answer

AGAMREE receives South Korea designations (Jun 02, 2026, 6 articles).

Question 8

Who is Santhera Pharmaceuticals most connected to?

Accepted Answer

Top relationships: Nxera Pharma, Nxera Pharma.

Question 9

How did the "AGAMREE receives South Korea designations" event impact Santhera Pharmaceuticals?

Accepted Answer

Santhera Pharmaceuticals will receive sales, milestone payments, and royalties from the net sales of AGAMREE in South Korea, Japan, Australia, and New Zealand due to the licensing agreement with Nxera Pharma The Orphan Drug Designation and Global Innovative Products on Fast Track designation for AGAMREE in South Korea are positive developments for the company.

Question 10

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.